Healthcare Innovation January 6, 2023
Geert De Lombaerde

The pharmacy giant’s leaders say their healthcare services group should produce about $7 billion in sales this year.

On the heels of an M&A binge since the fall of 2021, Walgreens Boots Alliance’s moves to further grow its healthcare services lineup will be more tactical in the quarters ahead, CFO James Kehoe said Jan. 5.

“We’re taking a pause. We need to focus on integration activities,” Kehoe said on a conference call discussing Walgreen’s results for the three months ended Nov. 30. “We’re not going to go out and do a $2 billion or $3 billion acquisition of a health tech company. We’re likely to be very targeted, and it will be in the hundreds of millions, not in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Post-Acute Care, Primary care, Provider, Specialist care, Trends
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
Let The Numbers Speak: Prescription Drug Provisions In The Inflation Reduction Act

Share This Article